fingolimod hydrochloride has been researched along with bilirubin in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (bilirubin) | Trials (bilirubin) | Recent Studies (post-2010) (bilirubin) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 25,921 | 1,337 | 5,871 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | bilirubin (IC50) |
|---|---|---|---|
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3884 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.3183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Fukai, M; Furukawa, H; Hayashi, T; Ishikawa, H; Jin, MB; Kishida, A; Magata, S; Masuko, H; Nagashima, K; Ogata, K; Omura, T; Shimamura, T; Suzuki, T; Taniguchi, M; Todo, S; Yamashita, K | 1 |
| Hartmann, S; Kovarik, JM; Picard, F; Riviere, GJ; Schmidt, HH; Schmouder, RL; Voss, B; Wagner, F; Weiss, M | 1 |
1 trial(s) available for fingolimod hydrochloride and bilirubin
| Article | Year |
|---|---|
Fingolimod (FTY720) in severe hepatic impairment: pharmacokinetics and relationship to markers of liver function.
Topics: Adult; Area Under Curve; Bilirubin; Biomarkers; Female; Fingolimod Hydrochloride; Half-Life; Heart Rate; Humans; Immunologic Factors; Liver Diseases, Alcoholic; Liver Function Tests; Lymphocyte Count; Male; Middle Aged; Propylene Glycols; Protein Binding; Prothrombin Time; Sphingosine | 2006 |
1 other study(ies) available for fingolimod hydrochloride and bilirubin
| Article | Year |
|---|---|
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs.
Topics: Animals; Bilirubin; Cyclosporine; Dogs; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Immunosuppressive Agents; Liver Transplantation; Propylene Glycols; Sphingosine; Survival Rate; Tacrolimus; Time Factors | 2000 |